유럽 ​​다운증후군 시장 – 2028년까지의 산업 동향 및 예측

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

유럽 ​​다운증후군 시장 – 2028년까지의 산업 동향 및 예측

  • Pharmaceutical
  • Published Report
  • Mar 2021
  • Europe
  • 350 Pages
  • 테이블 수: 238
  • 그림 수: 18

>유럽 ​​다운 증후군 시장, 질병 유형별(21번 삼염색체, 전좌 다운 증후군, 모자이크 다운 증후군), 치료( 진단 , 요법), 최종 사용자(병원, 진료소, 홈 케어 시설, 치료 센터, 기타), 유통 채널(직접 입찰, 소매 판매, 기타), 국가(독일, 영국, 프랑스, ​​이탈리아, 스페인, 러시아, 폴란드, 스위스, 네덜란드, 헝가리, 오스트리아, 노르웨이, 아일랜드, 터키, 리투아니아 및 유럽의 나머지 지역) 산업 동향 및 2028년까지의 예측

유럽 ​​다운증후군 시장시장 분석 및 통찰력: 유럽 다운 증후군 시장

다운 증후군 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년부터 2028년까지의 예측 기간 동안 13.78%의 CAGR로 성장하고 있으며 2028년까지 7억 2,512만 달러에 도달할 것으로 예상된다고 분석했습니다. 질병 에 대한 인식이 높아지고 다운 증후군의 유병률이 증가하는 것이 예측 기간 동안 시장 수요를 촉진한 주요 요인입니다.

기술의 발전과 정부 지원의 확대는 예측 기간 동안 다운 증후군 시장 수요를 촉진한 주요 요인입니다 .

다운 증후군은 비정상적인 세포 분열로 인해 발생하는 유전적 질환 입니다 . 비정상적인 세포 분열은 21번 염색체의 추가 전체 또는 부분 사본을 얻습니다. 추가 유전 물질의 존재는 다운 증후군으로 이어지는 사람들 사이에서 신체적 및 발달적 변화를 일으킵니다. 다운 증후군과 관련된 가장 흔한 유전적 이상에는 정신 장애, 주로 어린이의 학습 장애가 포함됩니다.

인식 덕분에 이러한 사람들은 건강한 라이프스타일을 구축하기 위해 진보된 치료법과 함께 새로운 진단 방법을 선택할 수 있었습니다. 따라서 이는 질병에 대한 인식이 높아지면서 다운 증후군 시장 성장 의 원동력이 되고 있음 을 의미합니다 . 합병증은 특정 치료법을 이용할 수 없다는 것이 다운 증후군 시장 성장의 제약으로 작용한다는 것을 의미합니다. 다운 증후군 시장에서 활동하는 시장 참여자들은 다운 증후군 시장 성장의 기회로 작용하는 다양한 차원에서 사업을 촉진할 것으로 예상되는 여러 전략적 이니셔티브를 채택하고 있습니다. 제품 출시와 관련된 긴 승인 기간은 다운 증후군 시장 성장의 과제로 작용합니다.

다운 증후군 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 다운 증후군 시장 시나리오를 이해하려면 Data Bridge Market Research에 연락하여 분석가 브리핑을 요청하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.

유럽 ​​다운증후군 시장다운증후군 시장 범위 및 시장 규모

다운 증후군 시장은 질병 유형, 치료 , 최종 사용자 및 유통 채널을 기준으로 세분화됩니다 . 세그먼트 간 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.

  • 질병 유형에 따라 다운 증후군 시장은 21번 삼염색체, 전좌 다운 증후군, 모자이크 다운 증후군으로 세분화됩니다. 2021년에는 21번 삼염색체 세그먼트가 시장을 지배하고 있으며 다운 증후군 사례의 95% 이상이 21번 삼염색체입니다.
  • 치료를 기준으로 다운 증후군 시장은 진단 과 치료로 세분화됩니다. 2021년에는 대부분의 부모가 태아의 상태를 이해하기 위해 산전 검사를 실시함에 따라 진단 부문이 시장을 지배하고 있습니다.
  • 최종 사용자를 기준으로 다운 증후군 시장은 병원 , 진료소, 홈 케어 시설, 치료 센터 및 기타로 세분화됩니다. 2021년에는 병원 부문이 산전 검사의 주요 시설이기 때문에 시장을 지배하고 있습니다.
  • 유통 채널을 기준으로 다운증후군 시장은 직접 입찰, 소매 판매 및 기타로 세분화됩니다. 2021년에는 직접 입찰 부문이 병원과 진료소에서 진단 제품을 구매하는 주요 모드이기 때문에 시장을 지배하고 있습니다.

다운증후군 시장 국가 수준 분석

다운증후군 시장을 분석하고, 위에 언급된 대로 국가, 질병 유형, 치료 방법, 최종 사용자 및 유통 채널별로 시장 규모 정보를 제공합니다.

다운증후군 시장 보고서에서 다루는 국가는 독일, 영국, 프랑스, ​​이탈리아, 스페인, 러시아, 폴란드, 스위스, 네덜란드, 헝가리, 오스트리아, 노르웨이, 아일랜드, 터키, 리투아니아 및 기타 유럽 국가입니다.

유럽은 다운증후군 진단이 대부분 국가에서 일상적인 검사이기 때문에 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다. 독일은 유럽 시장에서 시장을 지배할 것으로 예상됩니다. 독일은 유럽에서 엄청난 시장 잠재력과 다운증후군 진단에 대한 더 높은 수요를 가진 선도적인 국가 중 하나입니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 유럽 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

정부 지원 증가와 연구 개발 증가로 다운증후군 시장 성장이 촉진되고 있습니다.

다운 증후군 시장은 또한 다운 증후군 약물 판매, 다운 증후군 기술 발전의 영향, 다운 증후군 시장에 대한 지원과 함께 규제 시나리오의 변화와 함께 다운 증후군 산업의 모든 국가적 성장에 대한 자세한 시장 분석을 제공합니다. 이 데이터는 2010년부터 2019년까지의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 다운증후군 시장 점유율 분석

다운증후군 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선이 있습니다. 위에 제공된 데이터 포인트는 다운증후군 시장과 관련된 회사의 초점에만 관련이 있습니다.

다운 증후군을 다루는 주요 기업으로는 F. Hoffmann-La Roche Ltd, PerkinElmer Inc., Illumina, Inc., Thermo Fisher Scientific Inc., Myriad Genetics, Inc., Abbott, Natera, Inc, AtilaBiosystems, Physio.co.uk, Novus Biologicals(Bio-Techne의 자회사), Down Syndrome Cork(Down Syndrome Ireland의 지사), Demeditec Diagnostics GmbH, Symbol, ASDclinic.co.uk 등이 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.

또한 전 세계 여러 회사에서 많은 제품 출시와 계약을 체결하면서 다운증후군 시장도 가속화되고 있습니다.

예를 들어,

  • 2017년 4월, Illumina, Inc.는 유럽에서 VeriSeq NIPT 솔루션을 출시했습니다. 출시된 제품은 염색체 이상을 스크리닝하는 데 사용되는 CE-IVD 마크가 있는 차세대 시퀀싱 기술 기반 접근 방식으로, 임신 10주 이내에 염색체 상태에 대한 정확한 정보를 제공하는 데 효과적임이 입증되었습니다. 이 제품 출시로 회사의 제품 포트폴리오가 확대되었고 전 세계 다운증후군 시장에서 뿌리를 내릴 수 있었습니다.

협력, 제품 출시, 사업 확장, 수상 및 인정, 합작 투자 및 시장 참여자의 기타 전략은 다운 증후군 시장에서 회사 시장을 강화하고 있으며, 이는 기업이 다운 증후군에 대한 제공을 개선하는 데에도 도움이 됩니다.


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE Down syndrome MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. treatment of Down syndrome LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET END USER COVERAGE GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Europe DOWN SYNDROME MARKET: Pipeline analysis
    1. PIPELINE PRODUCTS IMPACT ANALYSIS
    2. NNI-351
    3. ASPARAGINASE
    4. ANVS-401
    5. QUILLIVANT XR
    6. TOFACITINIB
    7. MEMANTINE HYDROCHLORIDE
    8. NICOTINE
    9. AEF0217
    10. ACI-24
  5. Europe DOwn syndrome Market: Laws and regulations
  6. Market Overview
    1. Drivers
      1. increasing prevalence OF DOWN syndrome
      2. rising demand of effective therapies
      3. rising awareness about the diseasE
      4. technological ADVANCEMENTS
      5. increasing government support
    2. RESTRAINTS
      1. UNAVAILABILITY OF any specific treatment
      2. Side Effects Associated With Down Syndrome Treatment Therapies
      3. high cost of diagnosis
    3. opportunities
      1. STRATEGIC INITIATIVES BY MARKET PLAYERS
      2. increasing research and development
      3. presence of pipeline therapies
      4. presence of reimbursement
    4. challenGes
      1. Lack of Skilled Proffessionals
      2. Long Process for Product Launch
      3. Transfer of COVID-19 Infections by Diagnostic Methods
  7. Impact of COVID-19 on Europe Down Syndrome Market
    1. Price Impact
    2. Impact on Supply Chain
    3. Impact on Demand
    4. Strategic Decisions for Manufacturers
    5. Conclusion
  8. Europe Down syndrome MARKET, BY disease Type
    1. overview
    2. trisomy 21
    3. translocation Down syndrome
    4. mosaic Down syndrome
  9. Europe Down syndrome MARKET, BY treatment
    1. overview
    2. diagnosis
      1. Screening Tests
        1. First Trimester
          1. Blood Test
          2. Nuchal Translucency Testing
        2. Integrated Screening Test
          1. First Trimester
          2. Second Trimester
        3. The Triple Screen or Quadraple Screen Test
        4. Ultrasound
        5. Cell Free DNA
      2. Diagnostic Tests
        1. Chronic Villus Sampling
        2. Amniocentesis
        3. Precutaneous Umbical Cord Sampling
    3. therapy
      1. Early Intervention Therapy
        1. Speech-Language Therapy
        2. Physical Therapy
        3. Occupational Therapy
        4. Others
      2. Assistive Technology
        1. Hearing Aids
        2. Glasses
        3. Others
      3. Surgery
        1. Atrioventricular Septal Defect (AVSD)
        2. Duodenal Atresia
        3. Others
      4. Others
  10. Europe Down syndrome MARKET, BY end user
    1. overview
    2. hospital
    3. clinics
    4. homecare setting
    5. others
  11. Europe Down syndrome MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. retail sales
    4. others
  12. EUROPE Down syndrome MARKET, by Geography
    1. europe
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Poland
      8. Switzerland
      9. Netherlands
      10. Hungary
      11. Austria
      12. Norway
      13. Ireland
      14. Turkey
      15. Lithuania
      16. Rest of Europe
  13. Europe Down syndrome market: COMPANY landscape
    1. company share analysis: Europe
  14. company profile
    1. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. Company ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. PerkinElmer Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Illumina, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. Thermo Fisher Scientific Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. Myriad Genetics, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    6. Abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. Abnova Corporation
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. ASDclinic.co.uk
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    9. AtilaBiosystems
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    10. Boston Children's Hospital
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    11. Boys Town National Research Hospital
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. Children's Hospital Colorado
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    13. Demeditec Diagnostics GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    14. Down Syndrome Cork
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. Mayo Clinic Health System
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    16. Natera, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. Next Biosciences
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. Novus Biologicals (A Subsidiary of Bio-Techne)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    19. Kid Sense Child Development Corporation Pty Ltd
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    20. Physio.co.uk.
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    21. Symbol
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
  15. questionnaire
  16. related reports

표 목록

TABLE 1 Europe Down syndrome market: Pipeline Analysis

TABLE 2 REGULATION imposed by several regulatory agencies in different regions

TABLE 3 Europe Down Syndrome Market, By Disease Type, 2019-2028 (USD Million)

TABLE 4 Europe Trisomy 21 in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 5 Europe Translocation Down Syndrome in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 6 Europe Mosaic Down Syndrome in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 7 Europe Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 8 Europe Diagnosis in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 9 Europe Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 10 Europe Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 11 Europe First Trimester in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 12 Europe Integrated Screening Test in Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 13 Europe Diagnostic Tests in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 14 Europe Therapy in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 15 Europe Therapy in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 16 Europe Early Intervention Therapy in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 17 Europe Assistive Technology in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 18 Europe Surgery in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 19 Europe Therapy in Down Syndrom Market, By End User, 2019-2028 (USD Million)

TABLE 20 Europe Hospital in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 21 Europe Clinics in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 22 Europe Homecare Setting in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 23 Europe Therapy Centers in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 24 Europe Others in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 25 Europe Down Syndrome Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 26 Europe Direct Tender in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 27 Europe Retail Sales in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 28 Europe Others in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 29 europe Down syndrome Market, By Country, 2019-2028 (USD Million)

TABLE 30 europe Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 31 europe Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 32 europe diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 33 europe screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 34 europe first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 35 europe integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 36 europe diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 37 europe therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 38 europe early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 39 europe assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 40 europe surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 41 europe Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 42 europe Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 43 germany Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 44 germany Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 45 germany diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 46 germany screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 47 germany first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 48 germany integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 49 germany diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 50 germany therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 51 germany early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 52 germany assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 53 germany surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 54 germany Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 55 germany Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 56 U.K. Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 57 U.K. Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 58 U.K. diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 59 U.K. screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 60 U.K. first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 61 U.K. integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 62 U.K. diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 63 U.K. therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 64 U.K. early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 65 U.K. assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 66 U.K. surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 67 U.K. Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 68 U.K. Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 69 france Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 70 france Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 71 france diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 72 france screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 73 france first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 74 france integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 75 france diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 76 france therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 77 france early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 78 france assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 79 france surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 80 france Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 81 france Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 82 italy Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 83 italy Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 84 italy diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 85 italy screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 86 italy first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 87 italy integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 88 italy diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 89 italy therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 90 italy early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 91 italy assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 92 italy surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 93 italy Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 94 italy Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 95 spain Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 96 spain Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 97 spain diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 98 spain screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 99 spain first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 100 spain integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 101 spain diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 102 spain therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 103 spain early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 104 spain assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 105 spain surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 106 spain Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 107 spain Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 108 russia Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 109 russia Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 110 russia diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 111 russia screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 112 russia first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 113 russia integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 114 russia diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 115 russia therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 116 russia early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 117 russia assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 118 russia surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 119 russia Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 120 russia Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 121 poland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 122 poland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 123 poland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 124 poland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 125 poland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 126 poland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 127 poland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 128 poland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 129 poland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 130 poland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 131 poland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 132 poland Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 133 poland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 134 switzerland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 135 switzerland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 136 switzerland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 137 switzerland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 138 switzerland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 139 switzerland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 140 switzerland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 141 switzerland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 142 switzerland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 143 switzerland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 144 switzerland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 145 switzerland Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 146 switzerland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 147 netherlands Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 148 netherlands Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 149 netherlands diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 150 netherlands screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 151 netherlands first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 152 netherlands integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 153 netherlands diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 154 netherlands therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 155 netherlands early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 156 netherlands assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 157 netherlands surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 158 netherlands Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 159 netherlands Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 160 hungary Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 161 hungary Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 162 hungary diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 163 hungary screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 164 hungary first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 165 hungary integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 166 hungary diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 167 hungary therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 168 hungary early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 169 hungary assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 170 hungary surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 171 hungary Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 172 hungary Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 173 austria Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 174 austria Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 175 austria diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 176 austria screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 177 austria first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 178 austria integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 179 austria diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 180 austria therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 181 austria early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 182 austria assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 183 austria surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 184 austria Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 185 austria Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 186 norway Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 187 norway Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 188 norway diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 189 norway screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 190 norway first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 191 norway integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 192 norway diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 193 norway therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 194 norway early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 195 norway assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 196 norway surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 197 norway Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 198 norway Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 199 ireland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 200 ireland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 201 ireland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 202 ireland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 203 ireland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 204 ireland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 205 ireland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 206 ireland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 207 ireland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 208 ireland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 209 ireland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 210 ireland Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 211 ireland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 212 turkey Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 213 turkey Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 214 turkey diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 215 turkey screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 216 turkey first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 217 turkey integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 218 turkey diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 219 turkey therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 220 turkey early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 221 turkey assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 222 turkey surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 223 turkey Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 224 turkey Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 225 lithuania Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 226 lithuania Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 227 lithuania diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 228 lithuania screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 229 lithuania first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 230 lithuania integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 231 lithuania diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 232 lithuania therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 233 lithuania early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 234 lithuania assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 235 lithuania surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 236 lithuania Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 237 lithuania Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 238 rest of europe Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

그림 목록

FIGURE 1 Europe DOWN SYNDROME MARKET: SEGMENTATION

FIGURE 2 EUROPE DOWN SYNDROME MARKET : DATA TRIANGULATION

FIGURE 3 Europe Down syndrome Market: DROC ANALYSIS

FIGURE 4 Europe Down syndrome market: Europe VS. REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Down syndrome Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Down syndrome MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Down syndrome MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE DOWN SYNDROME MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE down syndrome Market: MARKET END UsER COVERAGE GRID

FIGURE 10 EUROPE DOWN SYNDROME MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 Europe Down syndrome market: SEGMENTATION

FIGURE 12 Increasing PREVALENCE of Down syndrome and Other Related Disorders and Rising Demand for Effective therapies is DRIVing THE Europe Down syndrome MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 trisomy 21 SEGMENT is expected to account for the largest share of the Europe DOWN SYNDROME MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF EUROPE Down syndrome market

FIGURE 15 Europe Down syndrome market: BY disease type, 2020

FIGURE 16 Europe Down syndrome market: BY disease type, 2020-2028 (USD Million)

FIGURE 17 Europe Down syndrome market: BY disease type, CAGR (2020-2028)

FIGURE 18 Europe Down syndrome market: BY disease type, LIFELINE CURVE

FIGURE 1 Europe Down syndrome market: BY treatment, 2020

FIGURE 2 Europe Down syndrome market: BY treatment, 2020-2028 (USD Million).

FIGURE 3 Europe Down syndrome market: BY treatment, CAGR (2020-2028)

FIGURE 4 Europe Down syndrome market: BY treatment, LIFELINE CURVE

FIGURE 5 Europe Down syndrome market: BY end user, 2020

FIGURE 6 Europe Down syndrome market: BY end user, 2020-2028 (USD Million)

FIGURE 7 Europe Down syndrome market: BY end user, CAGR (2020-2028)

FIGURE 8 Europe Down syndrome market: BY end user, LIFELINE CURVE

FIGURE 9 Europe Down syndrome market: BY distribution channel, 2020

FIGURE 10 Europe Down syndrome market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 11 Europe Down syndrome market: BY distribution channel, CAGR (2020-2028)

FIGURE 12 Europe Down syndrome market: BY distribution channel, LIFELINE CURVE

FIGURE 13 europe Down syndrome market: SNAPSHOT (2020)

FIGURE 14 europe Down syndrome market: BY COUNTRY (2020)

FIGURE 15 europe Down syndrome market: BY COUNTRY (2021 & 2028)

FIGURE 16 europe Down syndrome market: BY COUNTRY (2021 & 2028)

FIGURE 17 europe Down syndrome market: BY treatment (2021-2028)

FIGURE 18 Europe Down syndrome market: company share 2020 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.